164 related articles for article (PubMed ID: 32287638)
21. Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation.
Park YD; Yoshioka A; Kawa K; Ishizashi H; Yagi H; Yamamoto Y; Matsumoto M; Fujimura Y
Bone Marrow Transplant; 2002 May; 29(9):789-94. PubMed ID: 12040478
[TBL] [Abstract][Full Text] [Related]
22. Coagulation disturbances in paediatric patients with hepatic veno-occlusive disease after stem cells transplantation.
Jevtić D; Vujić D; Zecević Z; Veljković D; Gazikalović S; Elezović I
Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():33-8. PubMed ID: 20229680
[TBL] [Abstract][Full Text] [Related]
23. Role of Initiating Supportive Care Preceding Veno-occlusive Disease Diagnosis Following Allogeneic Hematopoietic Stem Cell Transplantation in Children.
Rayner P; Spruit JL; Chu R; Yankelevich M; Henry M; Ravindranath Y; Savaşan S
J Pediatr Hematol Oncol; 2019 Aug; 41(6):e395-e401. PubMed ID: 30933024
[TBL] [Abstract][Full Text] [Related]
24. Successful Treatment of Veno-occlusive Disease, Transplantation-Associated Thrombotic Microangiopathy, and Acute Graft-vs-Host Disease in a Patient with Relapsed Epstein-Barr Hemophagocytic Lymphohistiocytosis After Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report.
Zhang C; Tan X; Yao H; Liu Y; Gao L; Gao L; Kong PY; Zhang X
Transplant Proc; 2019 Nov; 51(9):3159-3162. PubMed ID: 31711585
[TBL] [Abstract][Full Text] [Related]
25. TIPS for veno-occlusive disease following stem cell transplantation.
Schoppmeyer K; Lange T; Wittekind C; Niederwieser D; Caca K
Z Gastroenterol; 2006 Jun; 44(6):483-6. PubMed ID: 16773513
[TBL] [Abstract][Full Text] [Related]
26. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
Remberger M; Ringdén O
Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
[TBL] [Abstract][Full Text] [Related]
27. Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver.
Rosen HR; Martin P; Schiller GJ; Territo M; Lewin DN; Shackleton CR; Busuttil RW
Liver Transpl Surg; 1996 May; 2(3):225-32. PubMed ID: 9346652
[TBL] [Abstract][Full Text] [Related]
28. Low, fixed dose defibrotide in management of hepatic veno-occlusive disease post stem cell transplantation.
Bagal B; Chandrasekharan A; Chougle A; Khattry N
Hematol Oncol Stem Cell Ther; 2018 Mar; 11(1):47-51. PubMed ID: 28460209
[TBL] [Abstract][Full Text] [Related]
29. [Delayed Hepatic Veno-Occlusive Disease after Haploidentical Hematopoietic Stem Cell Transplantation:A Report of Six Cases].
Kang HZ; Zheng XL; Wang ZD; Han DM; Ding L; Wang HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1149-54. PubMed ID: 27531791
[TBL] [Abstract][Full Text] [Related]
30. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
Qureshi A; Marshall L; Lancaster D
Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
[TBL] [Abstract][Full Text] [Related]
31. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.
Kumar S; DeLeve LD; Kamath PS; Tefferi A
Mayo Clin Proc; 2003 May; 78(5):589-98. PubMed ID: 12744547
[TBL] [Abstract][Full Text] [Related]
32. Abdominal complications following hematopoietic stem cell transplantation.
del Campo L; León NG; Palacios DC; Lagana C; Tagarro D
Radiographics; 2014; 34(2):396-412. PubMed ID: 24617687
[TBL] [Abstract][Full Text] [Related]
33. Cost-Effectiveness of Defibrotide in the Prophylaxis of Veno-Occlusive Disease after Pediatric Allogeneic Stem Cell Transplantation.
Pichler H; Horner K; Engstler G; Poetschger U; Glogova E; Karlhuber S; Martin M; Eibler W; Witt V; Holter W; Matthes-Martin S
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1128-1133. PubMed ID: 28359910
[TBL] [Abstract][Full Text] [Related]
34. Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.
Dalle JH; Giralt SA
Biol Blood Marrow Transplant; 2016 Mar; 22(3):400-9. PubMed ID: 26431626
[TBL] [Abstract][Full Text] [Related]
35. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
36. Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.
Moscardó F; Sanz GF; de La Rubia J; Jiménez C; Saavedra S; Regadera A; Andreu R; García I; Plumé G; Martínez J; Martín G; Jarque I; Sanz MA
Bone Marrow Transplant; 2001 May; 27(9):983-8. PubMed ID: 11436110
[TBL] [Abstract][Full Text] [Related]
37. Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.
Pihusch M; Wegner H; Goehring P; Salat C; Pihusch V; Andreesen R; Kolb HJ; Holler E; Pihusch R
Bone Marrow Transplant; 2005 Oct; 36(7):631-7. PubMed ID: 16062176
[TBL] [Abstract][Full Text] [Related]
38. High Variability in the Reported Management of Hepatic Veno-Occlusive Disease in Children after Hematopoietic Stem Cell Transplantation.
Skeens MA; McArthur J; Cheifetz IM; Duncan C; Randolph AG; Stanek J; Lehman L; Bajwa R;
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1823-1828. PubMed ID: 27496218
[TBL] [Abstract][Full Text] [Related]
39. Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years.
Kalayoglu-Besisik S; Yenerel MN; Caliskan Y; Ozturk S; Besisik F; Sargin D
Transplant Proc; 2005 Jun; 37(5):2285-9. PubMed ID: 15964400
[TBL] [Abstract][Full Text] [Related]
40. Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation.
Giles FJ; Kantarjian HM; Kornblau SM; Thomas DA; Garcia-Manero G; Waddelow TA; David CL; Phan AT; Colburn DE; Rashid A; Estey EH
Cancer; 2001 Jul; 92(2):406-13. PubMed ID: 11466696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
